BIOMAT Database Logo BIOMAT Database Logo

Long-term efficacy of dual nucleoside reverse transcriptase inhibitor antiretroviral therapy in HIV-1 infection. 2002

Sandro Vento, and Massimiliano Lanzafame, and Francesca Cainelli, and Federica Faggian, and Ercole Concia, and Giulia Tositti, and Giorgio Masiero

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D018791 CD4 Lymphocyte Count The number of CD4-POSITIVE T-LYMPHOCYTES per unit volume of BLOOD. Determination requires the use of a fluorescence-activated flow cytometer. Lymphocyte Count, CD4,T4 Lymphocyte Count,CD4 Cell Counts,CD4 Counts,CD4+ Cell Counts,CD4+ Counts,CD4 Cell Count,CD4 Count,CD4 Lymphocyte Counts,CD4+ Cell Count,CD4+ Count,Count, T4 Lymphocyte,Counts, T4 Lymphocyte,Lymphocyte Count, T4,Lymphocyte Counts, CD4,Lymphocyte Counts, T4,T4 Lymphocyte Counts

Related Publications

Sandro Vento, and Massimiliano Lanzafame, and Francesca Cainelli, and Federica Faggian, and Ercole Concia, and Giulia Tositti, and Giorgio Masiero
Long-term complications of nucleoside reverse transcriptase inhibitor therapy.
April 2003, The AIDS reader,
Sandro Vento, and Massimiliano Lanzafame, and Francesca Cainelli, and Federica Faggian, and Ercole Concia, and Giulia Tositti, and Giorgio Masiero
[Antiretroviral therapy. NNRTI (non-nucleoside reverse transcriptase inhibitor)].
March 2000, MMW Fortschritte der Medizin,
Sandro Vento, and Massimiliano Lanzafame, and Francesca Cainelli, and Federica Faggian, and Ercole Concia, and Giulia Tositti, and Giorgio Masiero
Efficacy and tolerability of long-term efavirenz plus nucleoside reverse transcriptase inhibitors for HIV-1 infection.
January 2008, AIDS (London, England),
Sandro Vento, and Massimiliano Lanzafame, and Francesca Cainelli, and Federica Faggian, and Ercole Concia, and Giulia Tositti, and Giorgio Masiero
Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy.
January 2007, Antiviral therapy,
Sandro Vento, and Massimiliano Lanzafame, and Francesca Cainelli, and Federica Faggian, and Ercole Concia, and Giulia Tositti, and Giorgio Masiero
Long-term effectiveness of first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in Ghana.
January 2014, The Journal of antimicrobial chemotherapy,
Sandro Vento, and Massimiliano Lanzafame, and Francesca Cainelli, and Federica Faggian, and Ercole Concia, and Giulia Tositti, and Giorgio Masiero
HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
January 2009, The Southeast Asian journal of tropical medicine and public health,
Sandro Vento, and Massimiliano Lanzafame, and Francesca Cainelli, and Federica Faggian, and Ercole Concia, and Giulia Tositti, and Giorgio Masiero
Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection.
October 2009, The Annals of pharmacotherapy,
Sandro Vento, and Massimiliano Lanzafame, and Francesca Cainelli, and Federica Faggian, and Ercole Concia, and Giulia Tositti, and Giorgio Masiero
Inadvertent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in dual HIV-1/2 and HIV-2 seropositive West Africans: a retrospective study.
September 2009, The Journal of antimicrobial chemotherapy,
Sandro Vento, and Massimiliano Lanzafame, and Francesca Cainelli, and Federica Faggian, and Ercole Concia, and Giulia Tositti, and Giorgio Masiero
Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals.
October 2010, The Cochrane database of systematic reviews,
Sandro Vento, and Massimiliano Lanzafame, and Francesca Cainelli, and Federica Faggian, and Ercole Concia, and Giulia Tositti, and Giorgio Masiero
A novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase.
January 1992, Advances in experimental medicine and biology,
Copied contents to your clipboard!